Allergic Rhinitis in Children: Review of Indian Guidelines and Applicability of Fexofenadine Written By Dr. Kamal Kant Kohli28 Feb 2024 11:00 AM ISTAllergic rhinitis is a common disease that frequently occurs in children and adolescents. The disease has a significant burden that impacts sleep,...
Indian Guidelines Review on Allergic Rhinitis and Scope for Use of Fexofenadine and Montelukast Combination Written By Dr. Kamal Kant Kohli22 Jan 2024 11:00 AM ISTAllergic Rhinitis and Its Burden in India: Allergic rhinitis (AR) is a common inflammatory condition that affects the nasal mucosa and is...
Allergens in India and its Avoidance: Review through Indian Guidelines and Role of Fexofenadine-Montelukast Combination Written By Dr. Kamal Kant Kohli4 Dec 2023 12:13 PM ISTAllergic rhinitis is one of the most common allergic diseases, which appears to increase in India. Risk factors, diagnosis, and AR management vary...
Allergic Rhinitis: Latest Practice Insights and Treatment Approach Written By Dr. Kamal Kant Kohli3 Nov 2023 11:13 AM ISTUnderstanding Allergic Rhinitis(AR)Rhinitis is generally defined as inflammation of the nasal mucosa. Allergic rhinitis (AR) is a disease that affects...
Aero-Allergen induced Allergy:Indian Practitioners' Review and Scope of Fexofenadine Written By Dr. Kamal Kant Kohli18 Aug 2023 12:51 PM ISTWith a rise in the burden of non-communicable diseases, India is undergoing an epidemiological transformation with respect to environmental and...
Allergic Rhinitis-Phenotypes, Challenges, Therapeutic Approach and Role of Montelukast Fexofenadine Combination Written By Dr. Kamal Kant Kohli30 Jun 2023 11:45 AM ISTAtopic diseases are becoming increasingly prevalent worldwide, and allergic rhinitis (AR), an IgE-mediated inflammatory disease, is one among them....
Allergic Rhinitis-Approach to Holistic Management Written By Dr. Kamal Kant Kohli16 May 2023 11:30 AM ISTRhinitis is a common complaint in primary care with clinical presentation of symptoms, including runny nose, congestion, sneezing, mucosal pruritus,...
Revisiting Atopic March: Clinical Overview and Treatment Options Written By Dr. Kamal Kant Kohli22 April 2023 11:44 AM ISTAtopic March was first described more than 20 years ago as "the natural history of atopic manifestations, characterized by a typical sequence of...
Managing Atopic Diseases across Age Group Written By Dr. Kamal Kant Kohli27 Feb 2023 11:30 AM ISTAtopy is a genetic tendency to produce high IgE antibodies in response to common allergens, which increases the risk of developing atopic illnesses...
United Airway Disease and Clinical Applicability of Montelukast Fexofenadine Combination: Review Written By Dr. Kamal Kant Kohli20 Oct 2022 12:30 PM ISTRecent epidemiological, pathophysiological, and clinical scientific evidence has identified a relationship between upper and lower respiratory...
Respiratory Allergies in India and Clinical Review of Montelukast Fexofenadine Combination in its Management Written By Dr. Kamal Kant Kohli24 Sept 2022 11:57 AM ISTAllergic respiratory diseases (ARDs) are caused by the production of IgE antibodies to airborne allergens, causing various clinical manifestations in...
53 Drug Samples Fail To Clear CDSCO Test, 1 Declared Misbranded Susmita Roy12 Aug 2022 6:00 PM ISTNew Delhi: In its latest drug safety alert, the apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) has flagged 53 medicine...
